Xellera Therapeutics
Chemicals & Related Products · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesPhone Number
+852 26183356Website
www.xelleratherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Xellera Therapeutics
Xellera Therapeutics is Hong Kong's first GMP Contract Development and Manufacturing Organization (CDMO) specializing in Cell and Gene Therapy (CGT) and Advanced Therapy Products. Founded in 2018, the company operates state-of-the-art cGMP facilities that comply with international standards to ensure the quality, safety, and efficacy of its products. Xellera offers a comprehensive range of services including process development, custom manufacturing, and bioanalytical testing, catering to clients in the healthcare and life sciences sectors. The company aims to accelerate the development and manufacturing of innovative therapies, providing a one-stop solution for its partners.Explore more
Xellera Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xellera Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Xellera Therapeutics
Product Launch: Get notified when Xellera Therapeutics launches new products
Check out if Xellera Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Xellera Therapeutics recently announced quarterly report
Click to see if Xellera Therapeutics had a recent Job posting/layoffs
Xellera Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Xellera Therapeutics has new funding data
Check if Xellera Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Xellera Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Xellera Therapeutics
Compare insights from companies similar to Xellera Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$16.9M
51-200
Private
$175M
2020
AM
Akira MatsunoCo-Founder & President & Chief Operating Officer & Chief Financial Officer
Company Profile Activity
Activity Insights
Xellera Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xellera Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xellera Therapeutics.
Xellera Therapeutics Tech Stack
A closer look at the technologies used by Xellera Therapeutics
Xellera Therapeutics News & Media
Read more news
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xellera Therapeutics
Sign Up For FreeTo access detailed company insights
Xellera Therapeutics is Hong Kong's first GMP Contract Development and Manufacturing Organization (CDMO) specializing in Cell and Gene Therapy (CGT) and Advanced Therapy Products. Founded in 2018, the company operates state-of-the-art cGMP facilities that comply with international standards to ensure the quality, safety, and efficacy of its product... Read More
